UvA-DARE ( Digital Academic Repository ) Costimulatory molecules in human atherosclerotic plaques : an indication of antigen specific T lymphocyte activation

Atherosclerotic plaques contain inflammation, composed largely of macrophages and lymphocytes. A proportion of lymphocytes shows signs of activation, but the question arises whether they are activated in an antigen specific way. The expression of costimulatory molecules-receptors that provide accessory signals during antigen-specific activation is a prerequisite for such a condition. This aspect of inflammation in atherosclerotic lesions has not been investigated. Human arterial segments with diffuse intimal thickening, fatty streaks and atherosclerotic plaques were studied with immuno-single and double staining methods. Macrophages and T lymphocytes were stained with CD68 and CD3, respectively, and pan-B cell markers CD19 and CD22 were also used. Costimulatory molecules B7-1 and B7-2, together with their common ligand CD28, and CD27 with its ligand CD70, were stained with specific monoclonal antibodies. The results show that most T lymphocytes were CD27 positive and that only a subpopulation of these (5–15%) was positive also for B7-1, CD28 and CD70. Macrophages expressed B7-1, B7-2, CD28 and CD70, while macrophages positive for CD28 and CD70 have not been reported yet. The expression of costimulatory molecules was most pronounced in the superficial layers at the fibrous cap, but decreased towards the lipid core. This study shows, therefore, that atherosclerotic plaques provide costimulatory signals generally accepted as a prerequisite for adequate T cell stimulation. In addition, this study reveals that only approximately 5–15% of the lymphocytes appears actively involved in the inflammatory reaction. © 1997 Elsevier Science Ireland Ltd.

[1]  F. Ramsdell,et al.  Fas and FasL in the homeostatic regulation of immune responses. , 1995, Immunology today.

[2]  M. Rekhter,et al.  Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. , 1995, The American journal of pathology.

[3]  J. Witztum,et al.  T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[4]  F. Nestle,et al.  Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. , 1995, Journal of immunology.

[5]  G. Peltz,et al.  Costimulatory signals can selectively modulate cytokine production by subsets of CD4+ T cells. , 1995, Journal of immunology.

[6]  M. Rep,et al.  Heterogeneity of the circulating human CD4+ T cell population. Further evidence that the CD4+CD45RA-CD27- T cell subset contains specialized primed T cells. , 1995, Journal of immunology.

[7]  R. Effros,et al.  Decline in CD28+ T cells in centenarians and in long-term T cell cultures: A possible cause for both in vivo and in vitro immunosenescence , 1994, Experimental Gerontology.

[8]  T. Kipps,et al.  Elevated expression of CD80 (B7/BB1) and other accessory molecules on synovial fluid mononuclear cell subsets in rheumatoid arthritis. , 1994, Arthritis and rheumatism.

[9]  P. Linsley,et al.  Expression of the B7/BB1 activation antigen and its ligand CD28 in T-cell-mediated skin diseases. , 1994, The Journal of investigative dermatology.

[10]  G. Freeman,et al.  Role of CD27 in T cell immune response. Analysis by recombinant soluble CD27. , 1994, Journal of immunology.

[11]  P. Linsley,et al.  Expression of functional B7 and CTLA4 on rheumatoid synovial T cells. , 1994, Journal of immunology.

[12]  R. V. van Lier,et al.  CD27: marker and mediator of T-cell activation? , 1994, Immunology today.

[13]  M. Jenkins,et al.  Surface proteins involved in T cell costimulation , 1994, Journal of leukocyte biology.

[14]  R. Armitage Tumor necrosis factor receptor superfamily members and their ligands. , 1994, Current opinion in immunology.

[15]  A. Becker,et al.  Specialized membrane contacts between immunocompetent cells in human atherosclerotic plaques. , 1994, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[16]  R. V. van Lier,et al.  CD70 represents the human ligand for CD27. , 1994, International immunology.

[17]  G. Hansson,et al.  Immune mechanisms in atherosclerosis. , 1994, Coronary artery disease.

[18]  F. Nestle,et al.  T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28. , 1994, Blood.

[19]  J. Delabie,et al.  In situ expression of B7/BB1 on antigen-presenting cells and activated B cells: an immunohistochemical study. , 1993, International immunology.

[20]  L. Lanier,et al.  Functional Expression of B7/BB1 on Activated , 1993 .

[21]  G. Hansson Immune and inflammatory mechanisms in the development of atherosclerosis. , 1993, British heart journal.

[22]  C. Morimoto,et al.  CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functions. , 1992, Journal of immunology.

[23]  A. Becker,et al.  Macrophage differentiation in atherosclerosis. An in situ immunohistochemical analysis in humans. , 1992, The American journal of pathology.

[24]  J. Allison,et al.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones , 1992, Nature.

[25]  G. Hansson,et al.  T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[26]  M. Jenkins,et al.  CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. , 1991, Journal of immunology.

[27]  G. Freeman,et al.  Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. , 1991, Cellular immunology.

[28]  O. Majdic,et al.  CD27 expression by a distinct subpopulation of human B lymphocytes , 1990, European journal of immunology.

[29]  A. Becker,et al.  Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[30]  J. J. van den Oord,et al.  Multiple immunoenzyme staining techniques. Use of fluoresceinated, biotinylated and unlabelled monoclonal antibodies. , 1989, Journal of immunological methods.

[31]  G. Hansson,et al.  Immune mechanisms in atherosclerosis. , 1989, Arteriosclerosis.

[32]  R. V. van Lier,et al.  Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. , 1987, Journal of immunology.